Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Resources Medical Holdings Co ( (HK:1515) ) just unveiled an update.
China Resources Medical Holdings has announced senior management changes effective February 27, 2026, with the resignation of executive director and chief financial officer Yang Min due to a change in work arrangements. The board said Yang has no disagreements with the company and expressed appreciation for her contributions during her tenure.
At the same time, the company has appointed Wang Yuexing, a senior economist and director at controlling shareholder China Resources Healthcare Group, as an executive director for a three‑year term. Wang’s extensive experience in life sciences, aviation and pharmaceuticals, along with his remuneration structure tied to performance and market benchmarks, underscores the group’s effort to align leadership with strategic goals and shareholder interests.
The most recent analyst rating on (HK:1515) stock is a Sell with a HK$3.00 price target. To see the full list of analyst forecasts on China Resources Medical Holdings Co stock, see the HK:1515 Stock Forecast page.
More about China Resources Medical Holdings Co
China Resources Medical Holdings Company Limited operates a healthcare services business in China through a network of hospitals and related medical institutions. The group focuses on providing comprehensive medical services and is controlled by China Resources Healthcare Group Limited, positioning it within the broader China Resources conglomerate in the healthcare sector.
Average Trading Volume: 6,068,905
Current Market Cap: HK$3.98B
See more insights into 1515 stock on TipRanks’ Stock Analysis page.